Physician
Florida Pain Relief Group PLLC
Florida Pain Relief Group PLLC was paid $1.90M by Medicaid between Sep 2019 and Dec 2024, across 54 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 47% of everything it billed.
33Billing provider infoFLORIDA PAIN RELIEF GROUP PLLC
TAMPA, FL 33614
TAMPA, FL 33614
33aNPI1376994608assigned 06/28/2016
33bProvider typeAnesthesiology Physician
28Total paid$1.90M
24GClaims190,181
24DCodes billed54
24AFirst – last monthSep 2019 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in Florida
Rank by total paid#4 of 148
Median peer was paid$20K
This provider vs. median95×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official GARI, TRACIE controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 472 | $545.15 | |
| 2020 | 12,477 | $28K | |
| 2021 | 22,043 | $428K | |
| 2022 | 49,912 | $610K | |
| 2023 | 82,157 | $511K | |
| 2024incomplete | 23,120 | $324K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 47% | 75,850 | 45,778 | $901K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 37,609 | 25,388 | $334K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 17% | 29,700 | 17,602 | $324K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8.9% | 3,116 | 2,061 | $169K |
| 64493 | 2.2% | 2,339 | 1,038 | $42K | |
| 64494 | <1% | 2,610 | 1,020 | $16K | |
| 95913 | <1% | 138 | 80 | $12K | |
| 80358 | <1% | 1,911 | 1,314 | $9K | |
| 80361 | <1% | 2,851 | 1,865 | $8K | |
| 95886 | <1% | 204 | 67 | $5K | |
| 80365 | <1% | 2,294 | 1,540 | $5K | |
| 80332 | <1% | 894 | 690 | $4K |
42 more codes
| 80348 | <1% | 1,611 | $4K | |
| 64483 | <1% | 193 | $4K | |
| 83992 | <1% | 1,485 | $4K | |
| 80370 | <1% | 1,170 | $4K | |
| 80354 | <1% | 1,697 | $4K | |
| 80356 | <1% | 2,177 | $4K | |
| 80367 | <1% | 1,292 | $4K | |
| 80324 | <1% | 2,153 | $4K | |
| 80353 | <1% | 2,166 | $4K | |
| 80335 | <1% | 853 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 491 | $3K |
| 80373 | <1% | 1,175 | $3K | |
| 80359 | <1% | 1,853 | $3K | |
| 80360 | <1% | 1,392 | $3K | |
| 80346 | <1% | 1,543 | $3K | |
| 80362 | <1% | 802 | $2K | |
| 80372 | <1% | 675 | $2K | |
| 80364 | <1% | 1,185 | $2K | |
| 80357 | <1% | 655 | $2K | |
| 80368 | <1% | 562 | $2K | |
| 64484 | <1% | 185 | $1K | |
| 80369 | <1% | 453 | $1K | |
| 64635 | <1% | 287 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 56 | $770.41 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,340 | $609.31 |
| 80299 | <1% | 352 | $478.18 | |
| 99441 | <1% | 68 | $474.56 | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 206 | $468.34 |
| 64495 | <1% | 40 | $464.64 | |
| 64636 | <1% | 289 | $280.40 | |
| 80305 | <1% | 27 | $237.56 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 49 | $201.44 |
| 62370 | <1% | 17 | $91.75 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 25 | $53.67 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 301 | $31.26 |
| 64490 | 0% | 251 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 338 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 704 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 208 | $0.00 |
| 99442 | 0% | 33 | $0.00 | |
| 64491 | 0% | 275 | $0.00 | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGARI, TRACIE (CHIEF ADMINISTRATIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Charles K Friedman DO PA | St Petersburg, FL | $2.96M |
| West Park Surgery Center LLC | Pinellas Park, FL | $2.37M |
| Medical Tox Labs, LLC | Tampa, FL | $655K |
| Texas Pain Relief Group PLLC | Hurst, TX | $507K |
| Physician Partners of America Crna Operations LLC | Hurst, TX | $349K |
| Medhat F. Mikhael, M.D., INC | Fountain Valley, CA | $341K |
| Sun City Center Ambulatory Surgery Center, LLC | Ruskin, FL | $274K |
| Medical Dna Labs, LLC | Tampa, FL | $107K |
| Richard L Smith MD PA | Orlando, FL | $74K |
| Merritt Island Outpatient Surgery Center, LLC | Merritt Island, FL | $15K |
| Hurst Ambulatory Surgery Center, LLC | Hurst, TX | $275.62 |
| Pain Institute of Tampa Bay, PLC | Tampa, FL | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.